Form 4: ADC Therapeutics SA Chief Accounting Officer Sells Shares to Cover Tax Obligations

Lisa Michelle Kallebo, Chief Accounting Officer of ADC Therapeutics SA, sold 6,503 common shares to cover tax obligations related to vesting restricted share units.

Summary

• Lisa Michelle Kallebo, the Chief Accounting Officer of ADC Therapeutics SA, sold 6,503 common shares on December 6, 2024.
• The sale was executed to cover tax withholding obligations associated with the vesting of previously granted restricted share units.
• Following the transaction, Ms. Kallebo directly owns 35,997 common shares of ADC Therapeutics SA.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, with no indication of positive or negative sentiment.

Industry Context

This is a routine transaction for executives who receive equity compensation. It is common for shares to be sold to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Sales of shares by executives to cover tax obligations are a common practice across publicly traded companies.
• The number of shares sold is relatively small compared to the total number of shares outstanding for ADC Therapeutics SA, suggesting this is a routine transaction rather than a significant change in ownership.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates

Keywords

SEC Form 4, ADC Therapeutics SA, Lisa Michelle Kallebo, Chief Accounting Officer, Share Sale, Tax Obligations, Restricted Share Units, ADCT